2 Stocks That Could Surge to Double Their Value Soon

Between 80% and 120% returns are possible with two exciting growth stocks in the cannabis sector. The values of the HEXO stock and Fire & Flowers stock could surge or more than double very soon.

| More on:
potted green plant grows up in arrow shape

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Two cannabis stocks are trading at deep discounts, but it shouldn’t be for long. Based on analysts’ forecasts, the values of HEXO (TSX:HEXO)(NASDAQ:HEXO) and Fire & Flower (TSX:FAF) could surge or double anytime soon. Lately, the movement in the cannabis sector has been similar to the pre-legalization of pot in Canada a few years ago.

Besides the consolidation happening, the outlook is bright for both companies, as the federal legalization of marijuana in the United States could come sooner than later. There’s no exact timetable, but there are reports that cannabis insurers in the U.S. are preparing for something big in 2022.

Insurance companies are waiting

According to a Reuters article, American insurance companies could be looking at a 10-fold increase in sales once the federal legalization of pot becomes real. National Cannabis Risk Management Association (NCRMA) chairman Rocco Petrilli said, “There is an overwhelming need for the right kinds of insurance.” The trade group is composed of 3,000 cannabis businesses.

If the industry were insured like normal businesses, insurance sales to cannabis businesses could grow to US$3 billion in five years, Petrilli added. Gavin Kogan, CEO of licensed cultivator Grupo Flor, said, “Whoever leads on providing reasonably priced insurance for this industry with the necessary coverage is going to be very, very successful.”

Aiming for top three

HEXO is not only a licensed cannabis producer but a consumer-packaged goods cannabis company. The weed stock isn’t doing great thus far in 2021. At $2.77 per share, investors are losing by 41%. Nonetheless, if you own HEXO today, hold the stock. Market analysts forecast a return potential of 121% to $6.12 in the next 12 months.

After three quarters in fiscal 2021 (nine months ended April 30, 2021), HEXO’s net revenue climbed 58% to $85 million versus the same period in fiscal 2020. Notably, net income was only $45.7 million from $377.9 million. Moreover, Truss CBD, a joint venture with Molson Coors, collared a 46% market share in the beverage category in Canada.

Many things transpired recently, including the completed acquisitions of 48North and Redecan. The twin purchases form part of HEXO’s corporate growth strategy. Its goal is to become a top-three global cannabis products company.

Expanding U.S. retail footprint

Fire & Flower has a retail footprint in the U.S. through a licensing arrangement with American Acres. According to its CEO, Trevor Fencott, the strategic partnership early this year is a significant milestone. The expansion of its brand and technology in high-growth markets in the U.S. is ongoing.

The $315.9 million independent retailer is one of the many Canadian producers keenly awaiting the federal legalization of cannabis in the United States. It has the option to acquire American Acres when it happens. Alimentation Couche-Tard, the king of convenience stores, is also Fire & Flower’s high-profile investor and partner.

Fire & Flower and Couche-Tard share the view that cannabis sales could be convenience-driven soon. On the TSX, the weed stock trades at less than $1 ($0.92). However, market analysts have a 12-month average price target of $1.71 for FAF. Based on the forecasts, the return potential is 86%.

Exciting growth stocks

HEXO and Fire & Flower are exciting growth stocks in the cannabis sector. The share prices are incredibly low today, but the upside potential for would-be investors could be massive as federal legalization of cannabis in the U.S. draws near.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends ALIMENTATION COUCHE-TARD INC. The Motley Fool recommends HEXO Corp.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »